Two different types of bacteria—one genetically engineered and one from cheese—defend animal intestines from Vibrio cholerae infection.  

The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.

A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.

As the virus spreads in Democratic Republic of Congo, the World Health Organization is preparing to immunize people as soon as this week.

The increase is associated with travel to Europe, where large outbreaks are occurring.

The CEO of a biomedical startup had made headlines this year when he injected himself with an untested herpes vaccine in front of an audience.

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

Human naive T cells are far more heterogeneous than has long been appreciated, having implications for vaccine strategies.

The microbiologist’s research led to the development of the first human malaria vaccine.